Safety of COVID-19 mRNA vaccination in children with chronic urticaria

[1]  L. de Montjoye,et al.  Chronic spontaneous urticaria following COVID-19 vaccination , 2022, JAAD Case Reports.

[2]  S. Greenberger,et al.  Validation of UAS7 among Children with Chronic Spontaneous Urticaria. , 2022, The journal of allergy and clinical immunology. In practice.

[3]  L. Ambrosio,et al.  COVID-19 infection and BNT162b2 vaccine triggering sarcoid-like lesions in the same patient. Response to: Sarcoid-like reaction in a patient recovering from COVID-19 pneumonia , 2022, JAAD Case Reports.

[4]  M. Rämet,et al.  Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age , 2021, The New England journal of medicine.

[5]  K. Dhama,et al.  Anaphylactic and nonanaphylactic reactions to SARS-CoV-2 vaccines: a systematic review and meta-analysis , 2021, Allergy, Asthma & Clinical Immunology.

[6]  T. Zuberbier,et al.  The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria , 2021, Allergy.

[7]  I. Muntean,et al.  COVID-19 Disease Leading to Chronic Spontaneous Urticaria Exacerbation: A Romanian Retrospective Study , 2021, Healthcare.

[8]  D. Sasseville,et al.  Evaluating Comorbidities, Natural History, and Predictors of Early Resolution in a Cohort of Children With Chronic Urticaria , 2017, JAMA dermatology.

[9]  D. Hepner,et al.  Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. , 2006, The Journal of allergy and clinical immunology.